Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Enlyte Lobbying Outlooks for 2024
While we can’t predict the future, we can help shape it! At Enlyte, our team of experts are continually monitoring emerging trends
Specialty Solutions Spotlight: Cybersecurity Risks With Internet Connected Medical Devices
Are internet-connected medical devices a cybersecurity risk? The advent of the
Ask The Pharmacist: Fixed-Dose Combination Drugs in Workers’ Comp
Beyond convenience, are there advantages in the use of fixed-dose combination drug products? Fixed-dose combination drug products (FDCDPs
Enlyte’s 2024 Trends Report Addresses Top Challenges in the P&C Industry
Industry leaders offer unique data and strategies to address trending issues including generative AI, provider shortages, drug costs and regula
IAIABC Forum 2024
At The Forum, the IAIABC's committees and councils discuss policy and administrative issues in workers' compensation, and attendees may also take p
RIMS Annual Conference & Exhibition 2024
RIMS 2024 Annual Conference & Exhibition is the premier event for the risk management community. RIMS features not only the largest exhibi